GUFIC BIOSCIENCES
Back to Balance Sheet
|
GUFIC BIOSCIENCES Last 5 Year Contingent Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹6.71 Cr | ₹3.90 Cr | ₹14 Cr | ₹37 Cr | ₹4.83 Cr |
What is the latest Contingent Liabilities ratio of GUFIC BIOSCIENCES ?
Year | Contingent Liabilities |
---|---|
Mar2023 | ₹6.71 Cr |
Mar2022 | ₹3.90 Cr |
Mar2021 | ₹14 Cr |
Mar2020 | ₹37 Cr |
Mar2019 | ₹4.83 Cr |
How is Contingent Liabilities of GUFIC BIOSCIENCES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹6.71 Cr | 72.06 | |
Mar2022 | ₹3.90 Cr | -71.29 | |
Mar2021 | ₹14 Cr | -63.25 | |
Mar2020 | ₹37 Cr | 664.66 | |
Mar2019 | ₹4.83 Cr | - |
Compare Contingent Liabilities of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,308.4 Cr | -4% | 4.6% | 66.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | -4% |
4.6% |
66.1% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses